Acquisitions (Schedule of Fair Value of Identifiable Assets Acquired and Liabilities Assumed) (Details) (USD $) In Millions, unless otherwise specified	Mar. 28, 2014	Sep. 27, 2013	Mar. 28, 2014 Specialty Pharmaceuticals	Sep. 27, 2013 Specialty Pharmaceuticals	Mar. 19, 2014 Specialty Pharmaceuticals Cadence Pharmaceuticals, Inc.
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]
Cash and cash equivalents					$ 43.2
Inventory					21.0
Intangible assets					1,300.0
Goodwill	853.9	532.0	634.2	312.3	321.9
Other assets, current and non-current					18.0	[1]
Deferred tax liabilities, net					(296.6)
Other liabilities, current and non-current					(78.3)	[2]
Net assets acquired					1,329.2
Acquired accounts receivable					14.7
Acquired debt					$ 30.0

[1] This amount includes $14.7 million of accounts receivable, which is also the gross contractual value.

[2] This amount includes $30.0 million of pre-existing Cadence debt, which the Company repaid upon completion of the acquisition.